SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NTEG- Bloodless Glucose Monitor -- Ignore unavailable to you. Want to Upgrade?


To: steve h who wrote (158)6/22/1998 5:27:00 PM
From: BitWizrd  Respond to of 176
 
Whoever can get to market first with a non or nearly non-invasive system that is as accurate as todays technology will have a huge opportunity with parents of diabetic children

But today's technology is not very accurate.

How about a subcutaneous glucose sensor that can be injected into place with an ordinary syringe, which is powered and read by a PalmPilot or watch-sized device - that can resolve hundreds of parts per billion within a second?

Sensors for Medicine and Science, Inc. says they've developed (or are developing) a prototype device that does just that. When they come to market, I think any company producing any kind of device that relies on infrared reflectance (near or far) will be hard pressed to keep up their market share.



To: steve h who wrote (158)6/22/1998 11:42:00 PM
From: nestegg  Read Replies (1) | Respond to of 176
 
With such a low stock price on NTEG potential,
I envision (Just a feeling!) that NTEG could easily be
bought out by a major multinational competitor in the
field of Diabetes control and/or treatment.

I for one, am holding on to my Shares 'til that day, should
it come.

Does anyone know if further NTEG presentations have or will be
made at upcoming (or, just occurred?) national or int'l
Diabetes Seminars or meetings?